Can-Fite BioPharma Ltd.
(CANF)
undefined
undefined%
At close: undefined
1.58
-0.32%
After-hours Dec 13, 2024, 07:33 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| Net Income | -7.63M | -10.17M | -12.62M | -14.44M | -12.63M | -6.57M | -4.98M | -7.02M | -5.06M | -6.30M | -8.85M | -5.86M | -7.47M | -3.68M |
| Depreciation & Amortization | 15.00K | 14.00K | 14.00K | 12.00K | 14.00K | 14.00K | 19.85K | 18.46K | 16.39K | 12.07K | 16.65K | 23.02K | 57.28K | 78.64K |
| Stock-Based Compensation | 261.00K | 263.00K | 466.00K | 355.00K | 385.00K | 535.00K | 195.07K | 309.00K | 109.00K | 212.00K | 787.94K | 389.73K | 83.81K | 177.00K |
| Other Working Capital | -474.00K | -1.24M | 2.09M | -401.00K | 146.00K | 1.22M | -323.40K | 324.70K | 1.15M | -0.00 | 148.81K | - | -843.41K | - |
| Other Non-Cash Items | -139.00K | 396.00K | -46.00K | 1K | -5.00K | -12.41M | -2.59M | -1.47M | -1.09M | -79.61K | -203.02K | -116.70K | 2.53M | -189.68K |
| Deferred Income Tax | - | - | -94.00K | 11.00K | 212.00K | 13.14M | 278.51K | - | - | - | -153.34K | -91.54K | -34.68K | 95.27K |
| Change in Working Capital | -943.00K | -1.30M | 2.48M | 2.00M | 1.19M | 1.13M | -2.45M | -449.49K | 1.49M | -961.75K | -231.16K | 1.31M | -666.58K | -138.39K |
| Operating Cash Flow | -8.44M | -10.80M | -9.86M | -12.06M | -10.83M | -4.16M | -9.52M | -8.93M | -4.65M | -7.33M | -8.63M | -4.35M | -5.50M | -3.65M |
| Capital Expenditures | -2.00K | -9.00K | -11.00K | -26.00K | -3.00K | -33.00K | -6.91K | -10.40K | -45.34K | -9.50K | -12.35K | -4.55K | -21.28K | -30.16K |
| Acquisitions | - | - | - | - | - | - | -22.00K | - | 2.57K | - | - | - | - | - |
| Purchase of Investments | - | - | -14.50M | - | - | - | - | - | - | - | - | - | - | - |
| Sales Maturities Of Investments | - | 9.51M | - | - | - | - | -22.73K | - | - | - | - | - | - | - |
| Other Investing Acitivies | 500.00K | 9.51M | -14.50M | - | -250.00K | - | -22.00K | - | 2.56K | - | 2.01K | 24.63K | 42.83K | - |
| Investing Cash Flow | 498.00K | 9.50M | -14.51M | -26.00K | -253.00K | -33.00K | -29.64K | -10.40K | -42.78K | -9.50K | -10.34K | 20.07K | 21.54K | -30.16K |
| Debt Repayment | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | -2.59M | -715.00K | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | - | 20.46M | 715.00K | - | - | - | - | - | - | 1.02M | 37.04K | 20.61K | 410.40K | 302.99K |
| Financial Cash Flow | 9.14M | 20.46M | 20.46M | 17.68M | 10.17M | 4.39M | 4.88M | - | 12.38M | 11.47M | 13.22M | 1.50M | 4.64M | 3.38M |
| Net Cash Flow | 1.30M | -1.41M | -3.88M | 5.57M | -918.00K | 110.00K | -5.48M | -9.05M | 7.67M | 3.94M | 4.73M | -2.77M | -757.75K | -418.55K |
| Free Cash Flow | -8.44M | -10.81M | -9.87M | -12.09M | -10.84M | -4.19M | -9.53M | -8.94M | -4.70M | -7.34M | -8.64M | -4.35M | -5.52M | -3.68M |